Pancreatic Cancer Research

ResearcherNational Cheng Kung University HospitalActive in the last 2 years

Hao‐Chen Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6211-9686; OpenAlex author ID A5052568434, A5130831905. Sources: OpenAlex.

Their work

Papers
11 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 11

  1. TBC1D23 drives lymphatic metastasis in pancreatic ductal adenocarcinoma by altering EGFR cell surface dynamics and signaling. First author DOI 10.1007/s13402-026-01203-8↗
  2. Heparanase blockade sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy and unleashes antitumor immunity. First author DOI 10.1016/j.biopha.2026.119442↗
  3. Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment. First author DOI 10.1158/1535-7163.mct-23-0767↗
  4. New insights into the role of adipocytes in pancreatic cancer progression: paving the way towards novel therapeutic targets. Co-author DOI 10.7150/thno.82911↗
  5. The Differential Clinical Impacts of Cachexia and Sarcopenia on the Prognosis of Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers14133137↗
  6. Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer. Co-author DOI 10.1186/s13148-020-00878-6↗
  7. Low CD8⁺ T Cell Infiltration and High PD-L1 Expression Are Associated with Level of CD44⁺/CD133⁺ Cancer Stem Cells and Predict an Unfavorable Prognosis in Panc… Co-author DOI 10.3390/cancers11040541↗
  8. Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8. Co-author DOI 10.7150/thno.36830↗
  9. Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes. Co-author DOI 10.3390/jcm7120502↗
  10. Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine. First author DOI 10.1186/s12943-015-0449-3↗
  11. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal … Co-author DOI 10.1002/cncr.28774↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yan‐Shen Shan · 11 shared papers, 2014–2026 · strength 1.80
  2. Ya‐Chin Hou · 10 shared papers, 2014–2026 · strength 1.48
  3. Ying‐Jui Chao · 6 shared papers, 2014–2026 · strength 0.81
  4. Chang-Jung Chen · 2 shared papers, 2024–2026 · strength 0.57
  5. Yu‐Chun Lin · 1 shared paper, 2023 · strength 0.26
  6. Po-Hsien Huang · 2 shared papers, 2019–2020 · strength 0.18
  7. Tai‐Jan Chiu · 2 shared papers, 2015–2019 · strength 0.15
  8. Nai‐Jung Chiang · 1 shared paper, 2022 · strength 0.15
  9. Chien‐Jui Huang · 1 shared paper, 2022 · strength 0.15
  10. Li‐Tzong Chen · 1 shared paper, 2019 · strength 0.09
  11. Yi‐Ching Wang · 1 shared paper, 2020 · strength 0.09
  12. Li-Yun Ding · 1 shared paper, 2020 · strength 0.09
  13. Ming-Chen Yang · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.